Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beer

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.
Nature Genetics|July 24, 2023
Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitionsRenhe Luo, Jielin Yan, Jin Woo Oh, et al.
Leukemia & Lymphoma|August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphomaLoretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Heart Rhythm O2|September 13, 2022
Left bundle branch area pacing in patients with heart failure and right bundle branch block: Results from International LBBAP Collaborative-Study GroupPugazhendhi Vijayaraman, Oscar Cano, Shunmuga Sundaram Ponnusamy, et al.
Blood|July 29, 2006
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformationPeter J Campbell, E Joanna Baxter, Philip A Beer, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
Physical Review Letters|May 1, 2001
Measurement of the resonant d(mu)t molecular formation rate in solid HDT A Porcelli, A Adamczak, J M Bailey, et al.
Nature Genetics|May 22, 2019
Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiationQing V Li, Gary Dixon, Nipun Verma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutationFederico Formenti, Philip A Beer, Quentin P P Croft, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Blood Advances|April 1, 2022
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research NetworkSimon Crouch, Daniel Painter, Sharon L Barrans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.
Nature Genetics|July 24, 2023
Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitionsRenhe Luo, Jielin Yan, Jin Woo Oh, et al.
Leukemia & Lymphoma|August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphomaLoretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Heart Rhythm O2|September 13, 2022
Left bundle branch area pacing in patients with heart failure and right bundle branch block: Results from International LBBAP Collaborative-Study GroupPugazhendhi Vijayaraman, Oscar Cano, Shunmuga Sundaram Ponnusamy, et al.
Blood|July 29, 2006
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformationPeter J Campbell, E Joanna Baxter, Philip A Beer, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
Physical Review Letters|May 1, 2001
Measurement of the resonant d(mu)t molecular formation rate in solid HDT A Porcelli, A Adamczak, J M Bailey, et al.
Nature Genetics|May 22, 2019
Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiationQing V Li, Gary Dixon, Nipun Verma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutationFederico Formenti, Philip A Beer, Quentin P P Croft, et al.
Pageof 27